New drug-related administration to be reformed

Published: 2004-08-16 06:56:00

Updated: 2004-08-16 06:56:00

The Korea Food and Drug Administration is contemplating a series of new measures designed to ameliorate new drugs-related regulations, said Lee Hee-sung, director-general of Drug Safety Division of the KFDA, in a report released by the Korea Health Industry Development Institute. He further noted...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK